HOME >> BIOLOGY >> NEWS
OneWorld Health plans to form network of volunteer pharmaceutical scientists for global health

San Francisco, Calif. Mar. 30, 2004 The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S., today announced its intent to develop a volunteer network of corporate and industry pharmaceutical scientists that would promote development of medicines for neglected diseases. The news was announced upon receipt of a grant from the Sapling Foundation (Woodside, Calif.), which will provide seed funding to initiate development of the community of volunteer scientists.

"We're very grateful to the Sapling Foundation for enabling us to tap the interest that pharmaceutical scientists have shown for global infectious diseases, and to harness their potential contributions toward developing cures," said Victoria Hale, Ph.D., founder and CEO of OneWorld Health. The concept for the volunteer scientist network arose after Dr. Hale was contacted by hundreds of pharmaceutical scientists globally, who offered to share their ideas, skills, accumulated research or contacts to advance the development of medicines for the benefit of the poorest people in the developing world.

She explained that scientists' voluntary services are analogous to what the law profession has long provided in the way of pro bono services to individuals and groups in need. "The contribution of pharmaceutical scientists' time and energy is fundamental to our nonprofit business model. A formal structure would leverage this enthusiasm and support," Dr. Hale said.

"Few outlets currently exist for pharmaceutical scientists to contribute their talents to global health," said Ching C. (CC) Wang, Ph.D., professor in the Dept. of Chemistry and Pharmaceutical Chemistry, University of California at San Francisco. "Through this network, OneWorld Health will provide scientists with opportunities to apply their expertise towards diseases that though virtually nonexistent in the developed world have disproportionate impact on disadvantaged patient populations in
'"/>

Contact: Joanne Hasegawa
jhasegawa@oneworldhealth.org
415-421-4700
Institute for OneWorld Health
30-Mar-2004


Page: 1 2

Related biology news :

1. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions
2. Institute for OneWorld Health nominated for the 2004 World Technology Awards
3. Institute for OneWorld Health receives Gates Foundation grant
4. OneWorld Health CEO outlines mutually beneficial collaborations between industry, nonprofits at BIO
5. Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health
6. OneWorld Health completes enrollment, treatment in Phase III India trial
7. Institute for OneWorld Health CEO advocates focus first on developing world markets
8. UC Santa Barbara donates discovery to OneWorld Health that may speed disease treatment
9. Victoria Hale of Institute for OneWorld Health Named Fellow by International Womens Forum
10. Health of worlds sea lions the focus of Wakefield Symposium
11. Healthy fats and oils essential to satisfy calorie-conscious consumers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/4/2019)... ... April 02, 2019 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that it will host a roundtable ... National Harbor Hotel, Oxon Hill, Maryland, on April 10-12, 2019. , On Thursday, ...
(Date:4/4/2019)... ... April 03, 2019 , ... R3 Stem Cell ... its nationwide Centers of Excellence. R3 wants patients to feel secure when they ... protect patients from Centers that use inferior regenerative biologics, protocols or amounts, R3 ...
(Date:3/29/2019)... , ... March 28, 2019 , ... ... (PT) programme, a new PT programme entirely dedicated to Chinese biobanks was launched ... and Environmental Repositories (ISBER) and the Biobank Branch, China Medicinal Biotech Association (BBCMBA). ...
Breaking Biology News(10 mins):
(Date:4/4/2019)... ... April 03, 2019 , ... LeadingBiotech, an exclusive event series ... announces its Boston CEO conference to be held May 28-29, 2019 at Boston’s ... with high-level panels and discussions from past, present and future change-makers. ...
(Date:3/27/2019)... ... , ... A leader in the field of Regenerative Veterinary Medicine, VetStem Biopharma ... and Canada since 2004. The primary indications for VetStem Regenerative Cell Therapy are ... cat, and horse. Recently, VetStem teamed up with the world-renowned San Diego Zoo ...
(Date:3/27/2019)... ... ... Lachman is sponsoring the event on April 1-4, where they will be ... team on site will be available to discuss strategies and tactics to support Facilities ... , Executives from Lachman participating at this year’s conference include Fran Zipp, President & ...
(Date:3/23/2019)... ... March 22, 2019 , ... ... Multi-Angle Light Scattering (MALS) detector , offering a revolutionary approach for the measurement ... proteins, and biopolymers. A novel optical design, a unique cell-block assembly, and a ...
Breaking Biology Technology:
Cached News: